Assessing the biosimilarity of protein drugs: New study shows method's precision
Friday, February 5, 2016 - 20:13
in Physics & Chemistry
A first-ever interlaboratory study of four versions of a therapeutic protein drug—all manufactured from living cells—reports that an established analytical tool akin to magnetic resonance imaging reliably assessed the atomic structures of the biologically similar products, yielding the equivalent of a fingerprint for each.